Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Mini Reviews in Medicinal Chemistry
|
September 24, 2005
Broad spectrum chemokine inhibitors related to NR58-3.14.3
David J Grainger, Jill Reckless, David J Fox
Medicinal Research Reviews
|
March 3, 2004
Tools for anti-inflammatory drug design: in vitro models of leukocyte migration
Emma K Frow, Jill Reckless, David J Grainger
Journal of Immunological Methods
|
January 31, 2006
A pattern of anti-carbohydrate antibody responses present in patients with advanced atherosclerosis
David E Mosedale, Anoop Chauhan, Peter M Schofield, et al.
Journal of Medicinal Chemistry
|
January 11, 2002
Design, synthesis, and preliminary pharmacological evaluation of N-acyl-3-aminoglutarimides as broad-spectrum chemokine inhibitors in vitro and anti-inflammatory agents in vivo
David J Fox, Jill Reckless, Stuart G Warren, et al.
Journal of Vascular Research
|
September 13, 2005
Broad-spectrum chemokine inhibition reduces vascular macrophage accumulation and collagenolysis consistent with plaque stabilization in mice
Jill Reckless, Laurie Tatalick, Sybille Wilbert, et al.
Journal of Medicinal Chemistry
|
May 12, 2009
Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors
David J Fox, Jill Reckless, Hannah Lingard, et al.
Current Protocols in Immunology
|
April 7, 2009
Measurement of human serum IgD levels
Catherine L Overed-Sayer, David E Mosedale, Margaret Goodall, et al.
Journal of Immunological Methods
|
May 23, 2006
A new sensitive and specific enzyme-linked immunosorbent assay for IgD
David E Mosedale, Manjinder S Sandhu, Jian'an Luan, et al.
The Analyst
|
February 8, 2003
Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension
Joanne T Brindle, Jeremy K Nicholson, Peter M Schofield, et al.
Journal of Medicinal Chemistry
|
February 4, 2005
Identification of 3-(acylamino)azepan-2-ones as stable broad-spectrum chemokine inhibitors resistant to metabolism in vivo
David J Fox, Jill Reckless, Sibylle M Wilbert, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Mini Reviews in Medicinal Chemistry
|
September 24, 2005
Broad spectrum chemokine inhibitors related to NR58-3.14.3
David J Grainger, Jill Reckless, David J Fox
Medicinal Research Reviews
|
March 3, 2004
Tools for anti-inflammatory drug design: in vitro models of leukocyte migration
Emma K Frow, Jill Reckless, David J Grainger
Journal of Immunological Methods
|
January 31, 2006
A pattern of anti-carbohydrate antibody responses present in patients with advanced atherosclerosis
David E Mosedale, Anoop Chauhan, Peter M Schofield, et al.
Journal of Medicinal Chemistry
|
January 11, 2002
Design, synthesis, and preliminary pharmacological evaluation of N-acyl-3-aminoglutarimides as broad-spectrum chemokine inhibitors in vitro and anti-inflammatory agents in vivo
David J Fox, Jill Reckless, Stuart G Warren, et al.
Journal of Vascular Research
|
September 13, 2005
Broad-spectrum chemokine inhibition reduces vascular macrophage accumulation and collagenolysis consistent with plaque stabilization in mice
Jill Reckless, Laurie Tatalick, Sybille Wilbert, et al.
Journal of Medicinal Chemistry
|
May 12, 2009
Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors
David J Fox, Jill Reckless, Hannah Lingard, et al.
Current Protocols in Immunology
|
April 7, 2009
Measurement of human serum IgD levels
Catherine L Overed-Sayer, David E Mosedale, Margaret Goodall, et al.
Journal of Immunological Methods
|
May 23, 2006
A new sensitive and specific enzyme-linked immunosorbent assay for IgD
David E Mosedale, Manjinder S Sandhu, Jian'an Luan, et al.
The Analyst
|
February 8, 2003
Application of chemometrics to 1H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension
Joanne T Brindle, Jeremy K Nicholson, Peter M Schofield, et al.
Journal of Medicinal Chemistry
|
February 4, 2005
Identification of 3-(acylamino)azepan-2-ones as stable broad-spectrum chemokine inhibitors resistant to metabolism in vivo
David J Fox, Jill Reckless, Sibylle M Wilbert, et al.
Page
of 3